Shares Of Monopar Therapeutics Inc (NASDAQ: MNPR) Gain 127.70% In A Month
Monopar Therapeutics Inc (NASDAQ:MNPR) has a beta value of 1.22 and has seen 0.41 million shares traded in the recent trading session. The company, currently
Monopar Therapeutics Inc (NASDAQ:MNPR) has a beta value of 1.22 and has seen 0.41 million shares traded in the recent trading session. The company, currently
In the last trading session, 1.11 million Monopar Therapeutics Inc (NASDAQ:MNPR) shares changed hands as the company’s beta touched 1.22. With the company’s per share
In last trading session, Monopar Therapeutics Inc (NASDAQ:MNPR) saw 1.51 million shares changing hands with its beta currently measuring 1.46. Company’s recent per share price
Monopar Therapeutics Inc (NASDAQ:MNPR) has a beta value of 1.42 and has seen 60.95 million shares traded in the last trading session. The company, currently
During the recent session, Monopar Therapeutics Inc (NASDAQ:MNPR)’s traded shares were 61.9 million, with the beta value of the company hitting 0.91. At the last
As of the last check on Friday for no relevant news, Monopar Therapeutics Inc. (Nasdaq: MNPR) was up 15.20% at $1.97 in after-hours trading. MNPR
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.